Sunday, July 26, 2020 8:40:57 AM
Recent EQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 09:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:45:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:43:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2024 09:10:19 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 02:50:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 09:05:08 PM
- Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates • Business Wire • 11/13/2024 09:01:00 PM
- Equillium to Present at the Stifel Healthcare Conference • Business Wire • 11/13/2024 01:00:00 PM
- Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer • Business Wire • 11/12/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/31/2024 04:19:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 11:05:36 AM
- Equillium Maintains Rights to Itolizumab Following Ono Partnership • Business Wire • 10/31/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 12:59:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 08:15:06 PM
- Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer • Business Wire • 10/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:14:15 PM
- Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit • Business Wire • 09/10/2024 12:00:00 PM
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/04/2024 12:00:00 PM
- Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference • Business Wire • 08/28/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:10:26 PM
- Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights • Business Wire • 08/08/2024 08:01:00 PM
- Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease • Business Wire • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:01:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 06:08:53 PM
- Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance • Business Wire • 07/18/2024 05:57:00 PM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM